Searching for Indirect Evidence and Extending the Network of Studies for Network Meta-Analysis: Case Study in Venous Thromboembolic Events Prevention Following Elective Total Knee Replacement Surgery

被引:9
作者
Dequen, Pascale [1 ]
Sutton, Alex J. [1 ]
Scott, David A. [2 ]
Abrams, Keith R. [1 ]
机构
[1] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England
[2] Oxford Outcomes Ltd, Oxford, England
基金
美国国家卫生研究院;
关键词
evidence synthesis; indirect treatment comparison; network meta-analysis; relative effectiveness; venous thromboembolism; ENOXAPARIN;
D O I
10.1016/j.jval.2014.02.013
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: To evaluate the effect of study identification methods and network size on the relative effectiveness and cost-effectiveness of recommended pharmacological venous thromboembolic events (VTEs) prophylaxis for adult patients undergoing elective total knee replacement surgery in the United Kingdom. Methods: A stepwise literature search specifically designed to identify indirect evidence was conducted to extend the original clinical review from the latest National Institute for Health and Care Excellence (NICE) VTE technology appraisal. Different network sizes or network orders, based on the successive searches, informed three network meta-analyses (NMAs), which were compared with a replicated base case. The resulting comparative estimates were inputted in an economic model to investigate the effect of network size on cost-effectiveness probabilities. Results: Searches increased the number of indirect comparisons between VTE interventions, progressively widening the relevant network of studies for NMA. Precision around mean relative treatment effects was increased as the network was extended from the base case to first-order NMA, but further extensions had limited effect Cost-effectiveness analysis results were largely insensitive to variation in clinical inputs from the different NMA orders. Conclusions: No standard methodology is currently recommended by NICE to identify the most relevant network of studies for NMA. Our study showed that optimizing the identification of studies for NMA can extend the evidence base for analysis and reduce the uncertainty in relative effectiveness estimates. Although in our example network extensions did not affect the acceptability of available treatments in VIE prevention based on cost-effectiveness results, it may in other applications.
引用
收藏
页码:416 / 423
页数:8
相关论文
共 30 条
[1]  
Ades AE, 2004, VALUE HEALTH, V13, P976
[2]  
[Anonymous], SYST REV CRDS GUID U
[3]  
[Anonymous], INTRO MIXED TREATMEN
[4]  
[Anonymous], 2010, VEN THROMB RED RISK
[5]  
[Anonymous], 2012, Evidence synthesis for decision making in healthcare
[6]  
Bristol-Myers Squibb Pharmaceuticals Ltd. and Pfizer Ltd, 2011, AP EL PREV VEN THROM
[7]   Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency [J].
Caldwell, Deborah M. ;
Welton, Nicky J. ;
Ades, A. E. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (08) :875-882
[8]   How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation? [J].
Cooper, Nicola J. ;
Peters, Jaime ;
Lai, Monica C. W. ;
Juni, Peter ;
Wandel, Simon ;
Palmer, Steve ;
Paulden, Mike ;
Conti, Stefano ;
Welton, Nicky J. ;
Abrams, Keith R. ;
Bujkiewicz, Sylwia ;
Spiegelhalter, David ;
Sutton, Alex J. .
VALUE IN HEALTH, 2011, 14 (02) :371-380
[9]   Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial [J].
Eriksson, B. I. ;
Dahl, O. E. ;
Rosencher, N. ;
Kurth, A. A. ;
Van Dijk, N. ;
Frostick, S. P. ;
Kalebo, P. ;
Christiansen, A. V. ;
Hantel, S. ;
Hettiarachchi, R. ;
Schnee, J. ;
Buller, H. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) :2178-2185
[10]   No Study Left Behind: A Network Meta-Analysis in Non-Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data [J].
Hawkins, Neil ;
Scott, David A. ;
Woods, Beth S. ;
Thatcher, Nicholas .
VALUE IN HEALTH, 2009, 12 (06) :996-1003